NL7304685A - - Google Patents

Info

Publication number
NL7304685A
NL7304685A NL7304685A NL7304685A NL7304685A NL 7304685 A NL7304685 A NL 7304685A NL 7304685 A NL7304685 A NL 7304685A NL 7304685 A NL7304685 A NL 7304685A NL 7304685 A NL7304685 A NL 7304685A
Authority
NL
Netherlands
Application number
NL7304685A
Other versions
NL157014B (nl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL7304685A publication Critical patent/NL7304685A/xx
Publication of NL157014B publication Critical patent/NL157014B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/72Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 spiro-condensed with carbocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/44Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D317/46Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
NL7304685.A 1972-04-07 1973-04-04 Werkwijze voor de bereiding van een perifeer vasodilatoir werkzaam, gesubstitueerd 5-(piperazinomethyl)-benzo(d)-1,3-dioxool, werkwijze voor de bereiding van een geneesmiddel met onder andere perifeer vasodilatoire werking, en gevormd geneesmiddel. NL157014B (nl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB1609872A GB1369379A (en) 1972-04-07 1972-04-07 Benzodioxole derivatives and processes for preparing them
US342284A US3917597A (en) 1972-04-07 1973-03-16 Benzodioxole compounds
US05/562,226 US4010267A (en) 1972-04-07 1975-03-26 Benzodioxole compounds

Publications (2)

Publication Number Publication Date
NL7304685A true NL7304685A (fr) 1973-10-09
NL157014B NL157014B (nl) 1978-06-15

Family

ID=27257339

Family Applications (1)

Application Number Title Priority Date Filing Date
NL7304685.A NL157014B (nl) 1972-04-07 1973-04-04 Werkwijze voor de bereiding van een perifeer vasodilatoir werkzaam, gesubstitueerd 5-(piperazinomethyl)-benzo(d)-1,3-dioxool, werkwijze voor de bereiding van een geneesmiddel met onder andere perifeer vasodilatoire werking, en gevormd geneesmiddel.

Country Status (11)

Country Link
US (2) US3917597A (fr)
JP (1) JPS5212715B2 (fr)
AU (1) AU466341B2 (fr)
BE (1) BE797905A (fr)
CA (1) CA984393A (fr)
CH (1) CH567502A5 (fr)
DE (1) DE2316920C3 (fr)
FR (1) FR2190443B1 (fr)
GB (1) GB1369379A (fr)
NL (1) NL157014B (fr)
SE (1) SE397830B (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4083853A (en) * 1973-09-08 1978-04-11 Eisai Co., Ltd. 1,3-Benzodioxol derivatives
US4081542A (en) * 1975-04-21 1978-03-28 Merck & Co., Inc. Piperazinylpyrazines
GB1560084A (en) * 1976-12-31 1980-01-30 Science Union & Cie Disubstituted piperazines processes for their preparation and pharmaceutical mompositions containing them
FR2418798A1 (fr) * 1978-03-03 1979-09-28 Science Union & Cie Nouvelles piperazines disubstituees, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
US4316899A (en) * 1979-08-24 1982-02-23 Beecham Group Limited Chromanone derivatives, a process for their preparation and compositions containing them
US4251530A (en) * 1980-02-19 1981-02-17 Merck & Co., Inc. 2-{[4-(6-Substituted-2-pyrazinyl)-1-piperazinyl]alkyl}-5-substituted-1,2,4-triazolo[4,3-a]pyridin-3(2H)-one analgesic agents
US4684651A (en) * 1981-03-17 1987-08-04 Mitsubishi Chemical Industries Limited Alkylenedioxybenzene and acid addition salts thereof useful as hypotensives
FR2519986A1 (fr) * 1982-01-21 1983-07-22 Adir Nouveaux derives de benzodioxine, leurs procedes de preparation et les compositions pharmaceutiques les renfermant
CH651027A5 (de) * 1982-11-12 1985-08-30 Sandoz Ag Heterocyclische verbindungen, ihre herstellung und verwendung.
FR2557570B1 (fr) * 1984-01-04 1986-04-18 Adir Nouveaux derives de la quinoleine, leur procede de preparation et les compositions pharmaceutiques les renfermant
JPS61214504A (ja) * 1985-03-20 1986-09-24 Daido Steel Co Ltd Sm−Co磁石の製造方法
JPS61214502A (ja) * 1985-03-20 1986-09-24 Daido Steel Co Ltd Sm−Co系磁石の製造方法
US4788290A (en) * 1987-12-11 1988-11-29 American Home Products Corporation Serotonergic pyrazine derivatives
DE69009887T2 (de) * 1989-07-26 1994-09-22 Ici Pharma Bizyklische Derivate.
US6040448A (en) * 1997-10-24 2000-03-21 Neurogen Corporation Certain 1-(2-naphthyl) and 1-(2-azanaphthyl)-4-(1-phenylmethyl) piperazines, dopamine receptor subtype specific ligands
WO2000012500A2 (fr) * 1998-09-02 2000-03-09 Neurogen Corporation 2-aryl-4-[4-heteroaryl]piperazin-1-yl methylimidazoles: ligands pour le sous-type de recepteur d4 de la dopamine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL127996C (fr) * 1963-11-19
FR1451232A (fr) * 1963-11-19 1966-01-07 Science Union Et Compagnie Nouveaux dérivés de la pyrimidine et leur procédé de préparation
GB1187680A (en) * 1967-11-15 1970-04-15 Science Union & Cie New Heterocyclic Substituted Piperazines

Also Published As

Publication number Publication date
FR2190443B1 (fr) 1976-03-05
DE2316920B2 (de) 1977-07-21
JPS497297A (fr) 1974-01-22
NL157014B (nl) 1978-06-15
AU5338373A (en) 1974-09-19
AU466341B2 (en) 1975-10-23
US4010267A (en) 1977-03-01
GB1369379A (en) 1974-10-09
DE2316920C3 (de) 1978-03-30
US3917597A (en) 1975-11-04
CA984393A (en) 1976-02-24
JPS5212715B2 (fr) 1977-04-08
SE397830B (sv) 1977-11-21
DE2316920A1 (de) 1973-10-18
CH567502A5 (fr) 1975-10-15
BE797905A (fr) 1973-10-08
FR2190443A1 (fr) 1974-02-01

Similar Documents

Publication Publication Date Title
AU465353B2 (fr)
CS166669B2 (fr)
CS167567B1 (fr)
CS164238B2 (fr)
CS166048B2 (fr)
CS158596B2 (fr)
JPS4921054A (fr)
CS159051B1 (fr)
CS164090B1 (fr)
CS170361B1 (fr)
CS170309B1 (fr)
CS169839B2 (fr)
CS168649B2 (fr)
CS168144B1 (fr)
JPS4954640A (fr)
CS167418B1 (fr)
CS166913B1 (fr)
CS162969B1 (fr)
CS154169B1 (fr)
CS154094B1 (fr)
CS154024B1 (fr)
CS153948B1 (fr)
CS153935B1 (fr)
CS153931B1 (fr)
CS152184B1 (fr)

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: SCIENCE UNION